E-ERAD-138 - RNA-seq of human cancer patient with BrafV600E mutant melanoma before and after treatment with PLX4032. EGA study.

Status
Released on 7 June 2013, last updated on 1 May 2014
Organism
Homo sapiens
Samples (1)
Protocols (2)
Description
We have collected material from a patient who had BrafV600E mutant melanoma that was treated with PLX4032. We have germline DNA from the patient and DNA and RNA from distinct lesions before and after treatment with PLX4032. We have transcriptome sequenced these samples to obtain a snap shot of the mechanisms of resistance that are operative.
Experiment type
RNA-seq of coding RNA 
Contact
MINSEQE
Exp. designProtocolsFactorsProcessedSeq. reads
Files
Investigation descriptionE-ERAD-138.idf.txt
Sample and data relationshipE-ERAD-138.sdrf.txt
Links